A Single-center, Open-label, Randomized, Multi-cohort, Crossover Study of Relative Bioavailability of Tablet Versus Capsule Formulation of E2006 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2013
At a glance
- Drugs Lemborexant (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- 07 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Dec 2012 Planned End Date changed from 1 Feb 2013 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 18 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.